Compare HNNA & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HNNA | CBUS |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.0M | 69.9M |
| IPO Year | N/A | 2017 |
| Metric | HNNA | CBUS |
|---|---|---|
| Price | $9.46 | $1.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 20.3K | ★ 172.4K |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | ★ 5.81% | N/A |
| EPS Growth | ★ 38.04 | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $35,538,000.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | $7.45 | ★ N/A |
| Revenue Growth | ★ 19.88 | N/A |
| 52 Week Low | $8.43 | $1.09 |
| 52 Week High | $13.54 | $3.40 |
| Indicator | HNNA | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 40.21 | 54.23 |
| Support Level | $9.21 | $1.60 |
| Resistance Level | $9.80 | $1.77 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 22.16 | 45.45 |
Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.